4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-13-053999
$CPIXCIK 0001087294operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 5:23 PM ET
Size
4.8 KB
Accession
0001209191-13-053999
Insider Transaction Report
Form 4
Lawrence Thomas R
Director
Transactions
- Sale
Common Stock
2013-11-21$4.99/sh−12,000$59,880→ 99,381 total
Footnotes (2)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc.
- [F2]Total now excludes 75,000 shares that had previously been deemed indirectly beneficially owned by Mr. Lawrence. These shares held in a trust were deemed to no longer be indirectly beneficially owned by Mr. Lawrence during 2013.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 5:23 PM ET
- Size
- 4.8 KB